RxDoctor Payments Data

Kellie King, APRN

Adult Health · Cleveland, OHNPI 1740890201

Payments from drug & device makers

$388in general payments, 2019–2025

Across 22 payments — averaging $17.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$131
  • United Therapeutics Corporation$82
  • Merck$32
  • Pfizer$30
  • Boston Scientific$29
  • Johnson & Johnson$28
  • plus $57 from 4 others

What the payments were for

  • Food & beverage$388100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$388 in reported general payments places this provider in the 50th percentile of 1,184 adult health providers in Ohio.

See all adult health providers in Ohio

Medicare billing

Part B allowed, 2024
$6,605
Medicare patients
64
Services billed
71

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter164$136,562
Spiriva RespimatTiotropium Bromide27$14,520
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr17$13,026
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$12,746
Breo ElliptaFluticasone/Vilanterol21$9,563
Spiriva HandihalerTiotropium Bromide15$7,596
Incruse ElliptaUmeclidinium Bromide13$6,051
Fluticasone-SalmeterolFluticasone Propion/Salmeterol30$4,330
Albuterol Sulfate HfaAlbuterol Sulfate137$3,673
SymbicortBudesonide/Formoterol Fumarate11$3,387
Montelukast Sodium41$560
Wixela InhubFluticasone Propion/Salmeterol11$532
Prednisone65$254
Fluticasone Propionate11$251
Azithromycin20$81

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Incruse Ellipta$14$165,203215 claims
AstraZenecaBreztri Aerosphere, Symbicort$14$16,13323 claims
Boehringer IngelheimSpiriva Respimat$15$14,52027 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 1,184 adult health providers in Ohio.

Other adult health in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →